Gene · 833
Papers4,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 4,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The crosslinks between ferroptosis and autophagy in asthma. | Front Immunol | 2023 | 37063888 | PubTator, text mining | PubMed |
| A close look at current γδ T-cell immunotherapy. | Front Immunol | 2023 | 37063836 | PubTator, text mining | PubMed |
| Engineered cell-based therapies in ex vivo ready-made CellDex capsules have therapeutic efficacy in solid tumors. | Biomed Pharmacother | 2023 | 37062216 | PubTator, text mining | PubMed |
| Recent advances in CAR T-cell therapy for lymphoma in China. | Clin Transl Oncol | 2023 | 37062016 | PubTator, text mining | PubMed |
| Ferroptosis landscape in prostate cancer from molecular and metabolic perspective. | Cell Death Discov | 2023 | 37061523 | PubTator, text mining | PubMed |
| Reactive sulfur species disaggregate the SQSTM1/p62-based aggresome-like induced structures via the HSP70 induction and prevent parthanatos. | J Biol Chem | 2023 | 37060999 | PubTator, text mining | PubMed |
| Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma. | Blood Adv | 2023 | 37058474 | PubTator, text mining | PubMed |
| A Comparison Controlled Study Examining Outcome for Children With Autism Receiving Intensive Behavioral Intervention (IBI). | Behav Modif | 2023 | 37056057 | PubTator, text mining | PubMed |
| Long-term outcomes following CAR T cell therapy: what we know so far. | Nat Rev Clin Oncol | 2023 | 37055515 | PubTator, text mining | PubMed |
| PCSK9, a novel immune and ferroptosis related gene in abdominal aortic aneurysm neck. | Sci Rep | 2023 | 37055467 | PubTator, text mining | PubMed |
| Quantifying requirements for mitochondrial apoptosis in CAR T killing of cancer cells. | Cell Death Dis | 2023 | 37055388 | PubTator, text mining | PubMed |
| Neoantigen-directed therapeutics in the clinic: where are we? | Trends Cancer | 2023 | 37055237 | PubTator, text mining | PubMed |
| Toward high-throughput engineering techniques for improving CAR intracellular signaling domains. | Front Bioeng Biotechnol | 2023 | 37051270 | PubTator, text mining | PubMed |
| Predictive short/long-term efficacy biomarkers and resistance mechanisms of CD19-directed CAR-T immunotherapy in relapsed/refractory B-cell lymphomas. | Front Immunol | 2023 | 37051246 | PubTator, text mining | PubMed |
| CAR T Cell Therapy: A Versatile Living Drug. | Int J Mol Sci | 2023 | 37047272 | PubTator, text mining | PubMed |
| The Glioma Immune Landscape: A Double-Edged Sword for Treatment Regimens. | Cancers (Basel) | 2023 | 37046685 | PubTator, text mining | PubMed |
| Aptamer-Based Strategies to Boost Immunotherapy in TNBC. | Cancers (Basel) | 2023 | 37046670 | PubTator, text mining | PubMed |
| Emerging Targeted Therapies for HER2-Positive Breast Cancer. | Cancers (Basel) | 2023 | 37046648 | PubTator, text mining | PubMed |
| Empowering the Potential of CAR-T Cell Immunotherapies by Epigenetic Reprogramming. | Cancers (Basel) | 2023 | 37046597 | PubTator, text mining | PubMed |
| 30 Years of Improved Survival in Non-Transplant-Eligible Newly Diagnosed Multiple Myeloma. | Cancers (Basel) | 2023 | 37046589 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/papers?page=34